March 16, 2021 Six Imperial researchers awarded leading health honours Six Imperial researchers have been appointed to prestigious research positions by the National Institute of Health Research (NIHR). They have been named as NIHR Senior Investigators – positions given to those who are deemed to be the most outstanding leaders of patient and people-based research within the NIHR faculty. They provide research leadership to the NIHR […]
January 11, 2021 Newly described condition causes loss of vertigo and imbalance in TBI patients A condition that causes loss of vertigo perception and imbalance has been diagnosed in traumatic brain injury patients for the first time. In a clinical study led by researchers at Imperial College London and clinicians at Imperial College Healthcare NHS Trust, out of 37 patients with acute traumatic brain injury (TBI), fifteen were diagnosed with a newly characterised neurological diagnosis called vestibular agnosia – a condition in the brain which results in loss of vertigo perception and imbalance. […]
April 15, 2020 Imperial welcomes world-leading health, research and education designation Imperial College Academic Health Science Centre has been redesignated an AHSC for a further five years. The prestigious designation from the National Institute of Health Research and NHS England/Improvement recognises Imperial College AHSC as a centre of excellence in health research, education and patient care. The Imperial College AHSC is a University-NHS partnership that aims to accelerate the translation of scientific breakthroughs into […]
March 3, 2020 Better children’s health and cancer treatment amongst aims of health partnership Professor Jonathan Weber has outlined his new vision for Imperial College Academic Health Science Centre (AHSC) over the next five years. The AHSC is a unique partnership between Imperial College London, The Institute of Cancer Research (ICR), Imperial College Healthcare NHS Trust, The Royal Marsden NHS Foundation Trust and the Royal Brompton & Harefield NHS […]
February 13, 2020 Kisspeptin hormone injection can boost brain activity associated with attraction The hormone kisspeptin can enhance brain activity associated with attraction, according to a new study. The researchers behind the early-stage work, published in JCI Insight, are exploring whether kisspeptin can ultimately be used to treat men with common psychosexual disorders – sexual problems which are psychological in origin such as low libido. The team are […]